ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

96 filings reported holding ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share as of Q2 2025.
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 29,072,911 shares of 53,136,600 outstanding shares and own 54.71% of the company stock.
Largest 10 shareholders include venBio Partners LLC (9,699,925 shares), Redmile Group, LLC (3,391,455 shares), TANG CAPITAL MANAGEMENT LLC (3,158,265 shares), Almitas Capital LLC (2,538,355 shares), VANGUARD GROUP INC (1,600,808 shares), ACADIAN ASSET MANAGEMENT LLC (1,267,999 shares), BANK OF AMERICA CORP /DE/ (1,035,127 shares), BlackRock, Inc. (716,297 shares), TWO SIGMA ADVISERS, LP (703,300 shares), and BANK OF MONTREAL /CAN/ (668,747 shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.